par Deleers, Marie;Breiman, Adrien;Daubie, Valéry 
;Maggetto, Carine ;Barreau, Isabelle;Besse, Tatiana;Clémenceau, Béatrice;Ruvoën-Clouet, Nathalie;Fils, Jean-François;Maillart, Evelyne ;Doyen, Virginie ;Mahadeb, Bhavna;Jani, Jacques C;Van Der Linden, Philippe ;Cannie, Mieke ;Hayef, Nabil ;Corazza, Francis ;Le Pendu, Jacques;El Kenz, Hanane
Référence International journal of infectious diseases, 104, page (242-249)
Publication Publié, 2021-03-01
;Maggetto, Carine ;Barreau, Isabelle;Besse, Tatiana;Clémenceau, Béatrice;Ruvoën-Clouet, Nathalie;Fils, Jean-François;Maillart, Evelyne ;Doyen, Virginie ;Mahadeb, Bhavna;Jani, Jacques C;Van Der Linden, Philippe ;Cannie, Mieke ;Hayef, Nabil ;Corazza, Francis ;Le Pendu, Jacques;El Kenz, Hanane Référence International journal of infectious diseases, 104, page (242-249)
Publication Publié, 2021-03-01
Article révisé par les pairs
| Résumé : | Susceptibility to Covid-19 has been found to be associated with the ABO blood group, with O type individuals being at a lower risk. However, the underlying mechanism has not been elucidated. Here, we aimed to test the hypothesis that Covid-19 patients might have lower levels of ABO antibodies than non-infected individuals as they could offer some degree of protection. |
